The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B
The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B
Although the incidence of Hepatitis B has been decreased a lot recently years, there are
 still quite a few chronic hepatitis B patients in China. The anti-virus drugs of western
 medicine such as Entecavir and Tenofovir have been proved effective on decreasing the serum
 hepatitis B virus (HBV) level, on the other hand, Chinese materia medica showed effective on
 TCM syndromes of chronic hepatitis B (CHB) such as hypochondriac pain, jaundice and abdominal
 mass. Besides, the hepatic fibrosis could be delayed after the appropriate treatment of TCM.
 This study is a multicenter, randomized, open label, parallel group clinical trial to
 evaluate the efficacy of two different traditional Chinese medicine (TCM) herbal treatment on
 chronic hepatitis B.
Inclusion Criteria:

 -  18<=age at treatment<=65 years old

 -  Was diagnosed as chronic hepatitis B (ICD10:K73.901) and one of the following Chinese
 syndromes: hypochondriac pain (TCD:BNG010), jaundice(TCD:BNG020) or abdominal mass
 (TCD:BNG040).

 Exclusion Criteria:

 -  Combined with other virus hepatitis or alcoholic hepatitis

 -  Combined with autoimmune disease

 -  Combined with liver cancer or cirrhosis

 -  Combined with severe hepatitis with or without complications

 -  Combined with unstable cardio-cerebrovascular disease

 -  Combined with severe lung, kidney, endocrine system, nervous system and hematological
 system diseases

 -  Combined with Tuberculosis

 -  Chronic hepatitis patients with ongoing INF treatment

 -  Woman with pregnancy or breasting feeding

 -  Mental disorder and can not express self clearly

 -  Cannot speak Chinese

 -  Allergic constitution or allergy to multiple drugs

 -  Refuse to enroll into the study